-
Pathologists have even found tiny deposits of prostate cancer cells in men in their 20s.
FORBES: Men, Cancer, & Hope
-
When the mice were kept calm and free of stress, the drug destroyed prostate cancer cells and inhibited tumor growth.
FORBES: New Study Shows How Stress Feeds Cancer Cells
-
Another approach, now being tested by Millennium Pharmaceuticals and, separately, by Medarex, is to develop smart antibodies that help destroy prostate cancer cells.
FORBES: On The Cover/Top Stories
-
One model used mice that were implanted with human prostate cancer cells and treated with a drug that is currently in clinical trial for prostate cancer treatment.
FORBES: New Study Shows How Stress Feeds Cancer Cells
-
Millennium's drug, now in early human trials, homes in on prostate cancer cells and aims to obliterate them with a precise dose of toxic chemotherapy while leaving surrounding tissue untouched.
FORBES: Men, Cancer & Hope
-
They include compounds that block bad genes responsible for spreading cancer into the bones, chemicals that prompt prostate cancer cells to destroy themselves and vaccines that train the body's killer T-cells to seek and destroy tumor cells.
FORBES: On The Cover/Top Stories
-
They include compounds that block bad genes responsible for spreading cancer into the bones, chemicals that prompt prostate cancer cells to destroy themselves and vaccines that train the body's killer T cells to seek and destroy tumor cells.
FORBES: On The Cover/Top Stories
-
These are part of the immune system and, if suitably treated with a substance called a fusion protein, can be used to make prostate-cancer cells vulnerable to immune attack.
ECONOMIST: Treating prostate cancer
-
And radiotherapy technology advances mean that far higher doses can be targeted more precisely on the prostate, killing more cancer cells with fewer treatments.
BBC: Prostate cancer
-
By combining the Gleason score (determined by a pathologist examining cancer cells under a microscope), the clinical stage (determined by a careful prostate exam and various scans) and the PSA level, we can stratify patients into "low, " "intermediate" and "high" risk categories.
WSJ: Are PSA Tests a Good Idea for Screening Men for Prostate Cancer?